Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
TenaRx
San Diego, California, United Statestenarx.com ↗
- Ownership
- Private
- Development stage
- Other
01
Overview
TenaRx is a San Diego-based biotechnology company and a majority-owned subsidiary of Biosplice Therapeutics. The company is focused on building a new therapeutic class around the selective inhibition of the CLK (Cdc2-like kinase) and DYRK (Dual-specificity tyrosine-phosphorylation-regulated kinase) families. These kinases are central regulators of cell fate, immune signaling, metabolism, and neurodevelopment, representing high-value nodes for drug development. TenaRx is currently advancing a pipeline of small-molecule programs targeting oncology, metabolic diseases such as diabetes, and neurodegenerative disorders. By leveraging precision kinase-targeted innovation, the company aims to deliver disease-modifying therapies for patients with significant unmet medical needs.
- Therapeutic areas
- OncologyEndocrinologyNeurologyMetabolic Disorders
- Modalities
- Small molecule
- Industry
- Biotech
Beyond the preview
Go deeper on TenaRx.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on TenaRx.